These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

405 related items for PubMed ID: 6089307

  • 81. [Angiotensin-converting enzyme inhibitors in the diagnosis and treatment of kidney diseases].
    Dzúrik R, Dzúriková V, Stefíková K.
    Vnitr Lek; 1991 Jun; 37(6):612-9. PubMed ID: 1897143
    [Abstract] [Full Text] [Related]

  • 82. Renovascular hypertension: treatment with the oral angiotensin-converting enzyme inhibitor enalapril.
    Jackson B, Murphy BF, Johnston CI, Kincaid-Smith P, Whitworth JA.
    Am J Nephrol; 1986 Jun; 6(3):182-6. PubMed ID: 3017107
    [Abstract] [Full Text] [Related]

  • 83. How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?
    MacFadyen RJ, Lee AF, Morton JJ, Pringle SD, Struthers AD.
    Heart; 1999 Jul; 82(1):57-61. PubMed ID: 10377310
    [Abstract] [Full Text] [Related]

  • 84. Diuretic herb Gomphrena celosioides Mart. (Amaranthaceae) promotes sustained arterial pressure reduction and protection from cardiac remodeling on rats with renovascular hypertension.
    de Paula Vasconcelos PC, Tirloni CAS, Palozi RAC, Leitão MM, Carneiro MTS, Schaedler MI, Silva AO, Souza RIC, Salvador MJ, Junior AG, Kassuya CAL.
    J Ethnopharmacol; 2018 Oct 05; 224():126-133. PubMed ID: 29842964
    [Abstract] [Full Text] [Related]

  • 85. Comparison of effects of enalapril plus hydrochlorothiazide versus standard triple therapy on renal function in renovascular hypertension.
    Franklin SS, Smith RD.
    Am J Med; 1985 Sep 27; 79(3C):14-23. PubMed ID: 2996342
    [Abstract] [Full Text] [Related]

  • 86. Hemodynamic, hormonal, and pharmacokinetic aspects of treatment with lisinopril in congestive heart failure.
    Dickstein K.
    J Cardiovasc Pharmacol; 1987 Sep 27; 9 Suppl 3():S73-81. PubMed ID: 2442558
    [Abstract] [Full Text] [Related]

  • 87. Comparison of treatment with lisinopril versus enalapril for congestive heart failure.
    Zannad F, van den Broek SA, Bory M.
    Am J Cardiol; 1992 Oct 08; 70(10):78C-83C. PubMed ID: 1329478
    [Abstract] [Full Text] [Related]

  • 88. Plasma lipid profiles and antihypertensive agents: effects of lisinopril, enalapril, nitrendipine, hydralazine, and hydrochlorothiazide.
    Williams LL, Lopez LM, Thorman AD, Quay GP, Stein GH, Mehta JL.
    Drug Intell Clin Pharm; 1988 Oct 08; 22(7-8):546-50. PubMed ID: 2843341
    [Abstract] [Full Text] [Related]

  • 89. Angiotensin-converting enzyme inhibitors: a comparative review.
    Raia JJ, Barone JA, Byerly WG, Lacy CR.
    DICP; 1990 May 08; 24(5):506-25. PubMed ID: 2188439
    [Abstract] [Full Text] [Related]

  • 90. The clinical pharmacology of lisinopril.
    Case DE.
    J Hum Hypertens; 1989 Jun 08; 3 Suppl 1():127-31. PubMed ID: 2550635
    [Abstract] [Full Text] [Related]

  • 91. Treatment of severe hypertension in a 14-year-old child: Successful blood pressure control with additive administration of captopril, an angiotensin-converting enzyme inhibitor, in a patient with bilateral renovascular hypertension.
    Zhang X, Xu Y, Chen X, Wang S, Li X, Yan X.
    Clin Exp Hypertens; 2017 Jun 08; 39(7):587-591. PubMed ID: 28621587
    [Abstract] [Full Text] [Related]

  • 92. Drug interactions with ACE inhibitors.
    Breckenridge AM.
    J Hum Hypertens; 1989 Jun 08; 3 Suppl 1():133-8. PubMed ID: 2674438
    [Abstract] [Full Text] [Related]

  • 93. [Antihypertensive effect of repeated oral administration of MK-0521 in 2-kidney Goldblatt hypertensive dogs].
    Oda M, Suzuki K, Ino Y, Sato T, Iwaki M.
    Nihon Yakurigaku Zasshi; 1989 Apr 08; 93(4):235-43. PubMed ID: 2545580
    [Abstract] [Full Text] [Related]

  • 94. Effects of the oral angiotensin-converting enzyme inhibitor MK-421 in human hypertension.
    Gavras H, Biollaz J, Waeber B, Brunner HR, Gavras I, Sackel H, Charocopos F, Davies RO.
    Clin Sci (Lond); 1981 Dec 08; 61 Suppl 7():281s-283s. PubMed ID: 6274572
    [Abstract] [Full Text] [Related]

  • 95. Vascular pressor responses in treated and untreated essential hypertension.
    Donnelly R, Elliott HL, Howie CA, Sumner DJ, Reid JL.
    J Cardiovasc Pharmacol; 1990 Aug 08; 16(2):191-6. PubMed ID: 1697373
    [Abstract] [Full Text] [Related]

  • 96. Effects of a new angiotensin-converting enzyme inhibitor, MK 421, in normal men and patients.
    Kono T, Oseko F, Ikeda F, Nakano R, Taniguchi A, Imura H, Endo J.
    Endocrinol Jpn; 1982 Oct 08; 29(5):615-22. PubMed ID: 6303766
    [Abstract] [Full Text] [Related]

  • 97. Usefulness of patch tests for diagnosing selective allergy to captopril.
    Gaig P, San Miguel-Moncin MM, Bartra J, Bonet A, García-Ortega P.
    J Investig Allergol Clin Immunol; 2001 Oct 08; 11(3):204-6. PubMed ID: 11831455
    [Abstract] [Full Text] [Related]

  • 98. Lisinopril in hypertensive patients with and without renal failure.
    van Schaik BA, Geyskes GG, Boer P.
    Eur J Clin Pharmacol; 1987 Oct 08; 32(1):11-6. PubMed ID: 3034622
    [Abstract] [Full Text] [Related]

  • 99. Aldosterone response to antihypertensive treatment.
    de Leeuw PW, van Soest GA, Birkenhäger WH.
    Clin Exp Hypertens A; 1982 Oct 08; 4(9-10):1913-21. PubMed ID: 6291819
    [Abstract] [Full Text] [Related]

  • 100. Angiotensin converting enzyme inhibition and renal insufficiency in patients with bilateral renovascular disease.
    Dominiczak A, Isles C, Gillen G, Brown JJ.
    J Hum Hypertens; 1988 Jun 08; 2(1):53-6. PubMed ID: 3070034
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.